Sudden death mortality in implantable cardioverter defibrillator patients.
Implantable cardioverter defibrillator (ICD) prevention of sudden cardiac death (SCD) is not absolute and our experience was reviewed to determine the frequency and nature of SCD in this population. The incidence and cause of mortality in 56 consecutive patients, who underwent ICD implantation beginning May 1982 with follow-up through May 19, 1990 were analyzed. Twenty-one patients died, 33% of the mortality was due to SCD, and 52% of deaths may be considered arrhythmic. The cumulative 1, 3, and 5 year SCD survivals were 93%, 89%, and 75%. All seven patients dying of SCD presented initially with SCD, all received previous shocks prior to SCD, and two of the seven patients had devices that were probably inactive at the time of death. We conclude that ICDs reduce but by no means eliminate arrhythmic death, particularly in those at highest risk for SCD. Arrhythmic death remained the most common cause of death in this population.
Gross
J
J
Department of Cardiothoracic Surgery, Montefiore Medical Center, Bronx, New York 10467.
Zilo
P
P
Ferrick
K
K
Fisher
J D
JD
Furman
S
S
D001145:Arrhythmias, Cardiac / Q000401:mortality* / Q000628:therapy; D002423:Cause of Death; D003645:Death, Sudden / Q000453:epidemiology*; D004554:Electric Countershock / Q000295:instrumentation*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D015996:Survival Rate